Novel germline TP53 variant (p.(Phe109Ile)) confers high risk of cancer.
Byrjalsen A, Stoltze UK, Lautrup C, Christensen LL, Mikkelsen T, Hjalgrim L, Brok JS, Dahl C, Schmiegelow K, Borgwardt L, Diness BR, Hansen TVO, Wadt KAW.
Byrjalsen A, et al.
J Med Genet. 2024 Oct 23;61(11):1023-1025. doi: 10.1136/jmg-2024-110255.
J Med Genet. 2024.
PMID: 39317423
No abstract available.